Join the Rexulti group to help and get support from people like you.
Rexulti News
What Medications Are Used to Treat Alzheimer's?
WEDNESDAY, June 21, 2023 – While there is no cure for Alzheimer's, there are medications that can help ease symptoms and slow the progression of this devastating disease. Alzheimer’s disease is the m...
Monthly News Roundup - May 2023
FDA Approves Once-Daily SGLT Inhibitor Inpefa to Treat Heart Failure Over 6 million Americans suffer from heart failure, with the prevalence expected to rise to 8 million by 2030. In response, the US...
Otsuka and Lundbeck Announce U.S. FDA Approval of Supplemental New Drug Application (sNDA) for Rexulti (brexpiprazole) for the Treatment of Agitation Associated with Dementia Due to Alzheimer’s Disease
PRINCETON, NJ and DEERFIELD, IL – May 10, 2023 – Otsuka Pharmaceutical, Co. Ltd. (Otsuka) and Lundbeck LLC (Lundbeck) announce the U.S. Food and Drug Administration (FDA) has approved the sup...
FDA Approves First Drug Meant to Ease Alzheimer's-Linked Agitation, Rexulti
THURSDAY, May 11, 2023 – A medication to treat agitation in Alzheimer's patients now has approval from the U.S. Food and Drug Administration. The FDA gave supplemental approval to Otsuka...
U.S. FDA Approves Labeling Update of Rexulti (brexpiprazole) for Maintenance Treatment of Schizophrenia
Princeton, New Jersey and Valby, Denmark – September 23, 2016 – Otsuka Pharmaceutical Development & Commercialization, Inc. (Otsuka) and H. Lundbeck A/S (Lundbeck) announced today that the U.S. Food a...
FDA Approves Rexulti (brexpiprazole) for Schizophrenia and Adjunctive Treatment for Major Depressive Disorder
Tokyo, Japan and Valby, Denmark – July 11, 2015 –Otsuka Pharmaceutical Co., Ltd. (Otsuka) and H. Lundbeck A/S (Lundbeck) announced today that the U.S. Food and Drug Administration (FDA) approved Rex...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Major Depressive Disorder, Schizophrenia, Depression